KAUSTUBH BHARDWAJ; HIMANSHI BHARDWAJ; AMIT TRIPATHI; LATIKA TOLIA; SNIGDH AGARWAL; DEVASHISH SRIVASTAVA; SWARAJ VERMA. FUTURE CHALLENGES AND EMERGING SAFETY CONCERNS OF GLP-1 RECEPTOR AGONISTS, DUAL INCRETIN AGONISTS, AND SGLT2 INHIBITORS. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 33, n. 2, p. 963–981, 2026. DOI: 10.69980/mng8r305. Disponível em: https://www.jptcp.com/index.php/jptcp/article/view/13620. Acesso em: 18 oct. 2026.